Evaluation of Prognostic Value of Inflammatory Markers in Children With Cancers

Головня, Г.; Сотников, В. М.; Байкова, Н.; Лебедева, В.

doi:10.15690/onco.v3i4.1633

Oncopediatria

2016

DOI: 10.15690/onco.v3i4.1633

|View full text |Cite

Evaluation of Prognostic Value of Inflammatory Markers in Children With Cancers

Г. Головня¹,

В. М. Сотников²,

Н. Байкова³

et al.

Abstract: ОБОСНОВАНИЕЛечение больных злокачественными новообра-зованиями относится к разряду сложных проблем. Проведение комбинированных и комплексных методов специального лечения с целью подавления системного воздействия злокачественной опухоли на организм сопряжено с развитием осложнений, нередко определяющих неблагоприятный прогноз заболевания. Такими осложнениями являются острая эндотоксемия, сепсис, септический шок, которые представляют собой типовой патологиче-ский процесс -структурно-функциональный ответ организм… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Presepsin as a marker of sepsis in oncological patients after surgical interventions

Guskova¹,

Morozova²,

Rozenko³

et al. 2022

jour

View full text Add to dashboard Cite

Purpose of the study. Analysis of the possibility of using presepsin in the early diagnosis of sepsis in cancer patients after extensive surgical interventions for tumors of the thoraco-abdominal localization.Materials and methods. The study included 27 people: 10 healthy individuals (control) and 17 patients who received surgical treatment at the National Medical Research Center of Oncology for malignant neoplasms of thoraco-abdominal localization. In the blood of all patients, studies of sepsis markers were performed: presepsin (P-SEP), highly sensitive CRP (hsCRP) (PATHFAST, Japan), procalcitonin (PCT), interleukin 6 (IL6) (Cobas e 411, Germany), as well as lactate, total leukocyte count (WBC) with a leukocyte formula, a blood culture test for suspected septic complications included in a routine examination. The studies were carried out before and on the 2nd day after the operation. Data were assessed by comparing P-SEP levels with hsCRP, PCT, IL6, lactate, WBC, blood culture test results, and the clinical status of patients. Depending on the data obtained, 2 groups were distinguished: I – patients with confirmed sepsis (3 people), II – without sepsis (14 people). Statistical processing was performed using STATISTICA 13.0.Results. In the control group, the level of P-SEP was 182.7 ± 11.9 pg/ml. In patients before surgery, the marker values were 213.7 ± 47.7 pg/ml, which did not differ statistically from the control data and did not go beyond the reference values, as did the content of PCT, hsCRP, IL6. On the 2nd day after surgery, all patients showed unidirectional changes, characterized by an increase in the levels of the studied parameters, but with varying degrees of intensity. The most significant was the increase in the concentration of presepsin. At the same time, it was noted that the level of presepsin on the 2nd day after surgery in patients of group I patients with confirmed sepsis averaged 2577.5 ± 1762.5 pg/ml with a maximum level 4340.0 pg/ml, and in group II with In the absence of confirmed bacteremia, there was an increase in the level of presepsin 1205.0 pg/ml. The data obtained correlated with the dynamics of changes in the concentration of other sepsis markers – hsCRP, PCT, IL6. Thus, the study of the level of presepsin, along with widely used markers – hsCRP, PCT, IL6, allows diagnosing sepsis in the early postoperative period in cancer patients.Conclusion. In patients with malignant neoplasms of thoracoabdominal localization, changes in the levels of sepsis markers in the early postoperative period can be used as a basis for prescribing antibiotic therapy. Presepsin may be recommended for use as an early marker of sepsis in patients with oncological pathology.

show abstract

Presepsin as a marker of sepsis in oncological patients after surgical interventions

Guskova¹,

Morozova²,

Rozenko³

et al. 2022

jour

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Evaluation of Prognostic Value of Inflammatory Markers in Children With Cancers

Cited by 1 publication

References 5 publications

Presepsin as a marker of sepsis in oncological patients after surgical interventions

Presepsin as a marker of sepsis in oncological patients after surgical interventions

Contact Info

Product

Resources

About